Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma
Immune checkpoint inhibitors (ICIs) have considerably expanded the effective treatment options for malignant melanoma.ICIs revert tumor-associated immunosuppression and potentiate T-cell mediated tumor clearance.Immune-related neurologic adverse events (irNAEs) manifest in the central (CNS) or peripheral nervous system (PNS) and most frequently pre